$32.89
0.21[0.64%]
Last update: 10:35AM Get Real Time Here
Arvinas
(NASDAQ:ARVN)Arvinas Stock (NASDAQ:ARVN), Analyst Ratings, Price Targets, Predictions
Arvinas Inc has a consensus price target of $66.67, established from looking at the 80 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., Wells Fargo, and Wedbush on May 17, 2024, May 9, 2024, and May 8, 2024. With an average price target of $68 between HC Wainwright & Co., Wells Fargo, and Wedbush, there's an implied 106.75% upside for Arvinas Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Wells Fargo
Wedbush
Stifel
Truist Securities
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Arvinas
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/17/2024 | Buy Now | 164.52% | HC Wainwright & Co. | Andrew Fein | → $87 | Reiterates | Buy → Buy | Get Alert |
| 05/09/2024 | Buy Now | 82.43% | Wells Fargo | Derek Archila | $63 → $60 | Maintains | Overweight | Get Alert |
| 05/08/2024 | Buy Now | 73.3% | Wedbush | Robert Driscoll | → $52 | Reiterates | Outperform → Outperform | Get Alert |
| 05/08/2024 | Buy Now | 106.75% | Stifel | Bradley Canino | $72 → $68 | Maintains | Buy | Get Alert |
| 05/08/2024 | Buy Now | 164.52% | HC Wainwright & Co. | Andrew Fein | → $87 | Reiterates | Buy → Buy | Get Alert |
| 04/15/2024 | Buy Now | 164.52% | HC Wainwright & Co. | Andrew Fein | $90 → $87 | Maintains | Buy | Get Alert |
| 04/12/2024 | Buy Now | 164.52% | HC Wainwright & Co. | Andrew Fein | $90 → $87 | Maintains | Buy | Get Alert |
| 03/25/2024 | Buy Now | 97.63% | Truist Securities | Joon Lee | → $65 | Reiterates | Buy → Buy | Get Alert |
| 02/29/2024 | Buy Now | 82.43% | Barclays | Peter Lawson | $26 → $60 | Maintains | Overweight | Get Alert |
| 02/28/2024 | Buy Now | 173.64% | HC Wainwright & Co. | Andrew Fein | → $90 | Reiterates | Buy → Buy | Get Alert |
| 02/28/2024 | Buy Now | 173.64% | BMO Capital | Etzer Darout | $89 → $90 | Maintains | Outperform | Get Alert |
| 02/28/2024 | Buy Now | 79.39% | Wedbush | Robert Driscoll | $33 → $59 | Maintains | Outperform | Get Alert |
| 02/28/2024 | Buy Now | 143.24% | Oppenheimer | Matthew Biegler | $95 → $80 | Reiterates | Outperform → Outperform | Get Alert |
| 02/15/2024 | Buy Now | 67.22% | Citigroup | Yigal Nochomovitz | $36 → $55 | Downgrade | Buy → Neutral | Get Alert |
| 02/14/2024 | Buy Now | 67.22% | Citigroup | Yigal Nochomovitz | $36 → $55 | Downgrade | Buy → Neutral | Get Alert |
| 02/01/2024 | Buy Now | 112.83% | Goldman Sachs | Paul Choi | → $70 | Initiates | → Buy | Get Alert |
| 12/19/2023 | Buy Now | 91.55% | Wells Fargo | Derek Archila | → $63 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 12/06/2023 | Buy Now | 21.62% | Jefferies | Akash Tewari | $32 → $40 | Upgrade | Hold → Buy | Get Alert |
| 11/20/2023 | Buy Now | 21.62% | Guggenheim | Michael Schmitz | → $40 | Upgrade | Neutral → Buy | Get Alert |
| 11/13/2023 | Buy Now | -39.19% | Morgan Stanley | Terence Flynn | $32 → $20 | Maintains | Equal-Weight | Get Alert |
| 11/08/2023 | Buy Now | 27.7% | Stifel | Bradley Canino | $46 → $42 | Maintains | Buy | Get Alert |
| 10/24/2023 | Buy Now | 9.46% | Citigroup | Yigal Nochomovitz | $72 → $36 | Maintains | Buy | Get Alert |
| 10/24/2023 | Buy Now | -20.95% | Barclays | Peter Lawson | $39 → $26 | Maintains | Overweight | Get Alert |
| 10/23/2023 | Buy Now | 67.22% | Piper Sandler | Edward Tenthoff | $70 → $55 | Maintains | Overweight | Get Alert |
| 10/23/2023 | Buy Now | -27.03% | Wedbush | Robert Driscoll | $27 → $24 | Upgrade | Neutral → Outperform | Get Alert |
| 09/07/2023 | Buy Now | 112.83% | Cantor Fitzgerald | Li Watsek | → $70 | Reiterates | Overweight → Overweight | Get Alert |
| 08/21/2023 | Buy Now | 118.91% | Citigroup | Yigal Nochomovitz | $77 → $72 | Maintains | Buy | Get Alert |
| 08/16/2023 | Buy Now | 97.63% | Truist Securities | Joon Lee | → $65 | Reiterates | Buy → Buy | Get Alert |
| 08/14/2023 | Buy Now | -2.71% | Morgan Stanley | Terence Flynn | $35 → $32 | Maintains | Equal-Weight | Get Alert |
| 08/09/2023 | Buy Now | 188.84% | Oppenheimer | Mark Breidenbach | → $95 | Reiterates | Outperform → Outperform | Get Alert |
FAQ
What is the target price for Arvinas (ARVN)?
The latest price target for Arvinas (NASDAQ: ARVN) was reported by HC Wainwright & Co. on May 17, 2024. The analyst firm set a price target for $87.00 expecting ARVN to rise to within 12 months (a possible 164.52% upside). 35 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Arvinas (ARVN)?
The latest analyst rating for Arvinas (NASDAQ: ARVN) was provided by HC Wainwright & Co., and Arvinas reiterated their buy rating.
When was the last upgrade for Arvinas (ARVN)?
The last upgrade for Arvinas Inc happened on December 19, 2023 when Wells Fargo raised their price target to $63. Wells Fargo previously had an equal-weight for Arvinas Inc.
When was the last downgrade for Arvinas (ARVN)?
The last downgrade for Arvinas Inc happened on February 15, 2024 when Citigroup changed their price target from $36 to $55 for Arvinas Inc.
When is the next analyst rating going to be posted or updated for Arvinas (ARVN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Arvinas, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Arvinas was filed on May 17, 2024 so you should expect the next rating to be made available sometime around May 17, 2025.
Is the Analyst Rating Arvinas (ARVN) correct?
While ratings are subjective and will change, the latest Arvinas (ARVN) rating was a reiterated with a price target of $0.00 to $87.00. The current price Arvinas (ARVN) is trading at is $32.89, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.